Casdin Capital’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-360,000
| Closed | -$50.4M | – | 33 |
|
|
2018
Q4 | $50.4M | Hold |
360,000
| – | – | 8.63% | 1 |
|
|
2018
Q3 | $61.5M | Hold |
360,000
| – | – | 7.47% | 1 |
|
|
2018
Q2 | $62.5M | Hold |
360,000
| – | – | 8.73% | 2 |
|
|
2018
Q1 | $41.5M | Hold |
360,000
| – | – | 7.3% | 1 |
|
|
2017
Q4 | $30.3M | Hold |
360,000
| – | – | 7.38% | 3 |
|
|
2017
Q3 | $33.2M | Hold |
360,000
| – | – | 9.36% | 1 |
|
|
2017
Q2 | $28.9M | Hold |
360,000
| – | – | 10.68% | 1 |
|
|
2017
Q1 | $15.1M | Hold |
360,000
| – | – | 8.94% | 3 |
|
|
2016
Q4 | $11.6M | Buy |
360,000
+69,000
| +24% | +$2.22M | 9.55% | 2 |
|
|
2016
Q3 | $7.62M | Sell |
291,000
-9,000
| -3% | -$236K | 6.17% | 6 |
|
|
2016
Q2 | $6.95M | Buy |
300,000
+50,000
| +20% | +$1.16M | 6.92% | 5 |
|
|
2016
Q1 | $6.84M | Sell |
250,000
-1,500
| -0.6% | -$41K | 7.85% | 1 |
|
|
2015
Q4 | $7.16M | Buy |
+251,500
| New | +$7.16M | 6.32% | 3 |
|